ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

• 4 Ways Home Visits Support Successful Rare Disease Clinical Trials

  Researchers, patients, pharma, and regulators face several obstacles when designing and conducting rare disease trials. Here, we delve into the importance of home visits in rare disease clinical trials.

• How Sponsors, CROs, And Tech Vendors Can Reduce Site Tech Overload

  Sites juggle dozens of applications, which increases their workload and limits their capacity. Sites need an industry-wide single sign-on experience that brings key systems and applications under one roof.

• Vaccine Trial Sees >90% eCOA Adherence

  Discover how we addressed vaccine trial challenges and drove remarkable success, achieving over 90% adherence to eCOA, ensuring active engagement from the trial participants, and yielding consistent, reliable trial data.

• 10 Questions To Ask When Looking For An eClinical Platform

  Stakeholders should ask these questions when aiming to enhance the integrity and efficiency of their clinical trials while minimizing risks associated with inadequate eClinical solutions.

• How DCTs Became The New Standard

  See how the core features of DCTs have become the new default clinical trial practices for a variety of therapeutic areas, almost four years after the 2020 pandemic brought about their rise.

• Addressing The Specific Complexities Of Oncology eCOA Clinical Trials

  What are the specific tools and keys to conduct eCOA trials in oncology successfully? This article identifies some of the relevant solutions to tackle oncology protocol complexities.

• Leveraging eCOA To Improve Patient Adherence In Clinical Trials

  Patient adherence is one of the biggest challenges in clinical trials. eCOA solutions offer intuitive and engaging tools that encourage participants to complete their assessments on time.

• Case Study: How Real-World Data Optimized An Oncology Clinical Trial Protocol

  Many challenges in running clinical trials are difficult to prepare for, but some, such as trial enrollment and study operational execution, can be proactively addressed thanks to advances in high-quality RWD.

• 2024 MedTech Regulatory Updates: 4 Areas Of Interest

  In 2024, McKinsey's projections foresee a promising year for the MedTech industry, driven by innovation but shadowed by regulatory uncertainty.

• ICH E6(R3) Is Here: What Your Centralized Monitoring Strategy Needs

  ICH E6(R3) turns best practices into regulatory mandates. Learn how to maintain sponsor accountability and implement proportionate centralized monitoring through a unified, auditable data layer.